Patent details
EP1552831 Title: Use of riluzole for treating multiple sclerosis
Basic Information
- Publication number:
- EP1552831
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP050014760
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Use of riluzole for treating multiple sclerosis
- French Title of Invention:
- Utilisation du riluzole pour le traitement de la sclérose en plaques
- German Title of Invention:
- Verwendung von Riluzol zur Behandlung Multipler Sklerose
- SPC Number:
Dates
- Filing date:
- 02/06/2000
- Grant date:
- 07/01/2009
- EP Publication Date:
- 07/01/2009
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/07/2005
- EP B1 Publication Date:
- 07/01/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 02/06/2010
- Expiration date:
- 02/06/2020
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/06/2000
- Name:
- VERENIGING VOOR CHRISTELIJK WETENSCHAPPELIJK
- Address:
- De Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands (NL)
Inventor
- Name:
- Polman Chris
- Address:
- Netherlands (NL)
Priority
1
- Priority Number:
- 99201788
- Priority Date:
- 04/06/1999
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 174328 P
- Priority Date:
- 04/01/2000
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/425;
| Filing date | Document type | Number of pages |
|---|